+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Specialty PACS Market Size, Share & Industry Trends Analysis Report By Deployment Model, By Type, By End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), By Country and Growth Forecast, 2021-2027

  • PDF Icon

    Report

  • 97 Pages
  • February 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5570989
The Latin America, Middle East and Africa Specialty PACS Market is expected to witness market growth of 9.4% CAGR during the forecast period (2021-2027).

The PACS systems work by using software & hardware components for acquiring images from devices like CT, ultrasound, radiographic devices, and MRI. The collected images are then converted into digital imaging & communications in medicine (DICOM) format. The PACS systems usually come with various features for 3D reconstruction, peer review, reporting, and improved working management.

The cloud based PACS store the medical imaging data of an organization at a secure off-site server. The PACS systems developers commonly use a hybrid cloud, where the primary images are stored on premises and the backups are securely stored in the cloud. 

Various initiatives taken by the government of UAE for development of healthcare industry are leading to the high adoption of specialty PACS systems across the nation. The advanced health care facilities such as virtual doctors & sanitizing robot introduced in the United Arab Emirates along with the increased demand for diagnostic imaging systems in Egypt is expected to have a significant impact on the growth of the specialty PACS market in the LAMEA region.

The Brazil market dominated the LAMEA Specialty PACS Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $63.4 million by 2027. The Argentina market is experiencing a CAGR of 10% during (2021 - 2027). Additionally, The UAE market is expected to exhibit a CAGR of 9.1% during (2021 - 2027).

Based on Deployment Model, the market is segmented into On premises and Cloud-based. Based on Type, the market is segmented into Radiology PACS, Orthopedics PACS, Oncology PACS, Pathology PACS, Ophthalmology PACS, Women’s health PACS, and Others. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novarad Enterprise Healthcare Solutions, Escalon Medical Corp., IBM Corporation, Siemens AG, Canon, Inc., INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., McKesson Corporation, Carestream Health, Inc., and Topcon Corporation.

Scope of the Study


Market Segments Covered in the Report:


By Deployment Model
  • On premises
  • Cloud-based

By Type
  • Radiology PACS
  • Orthopedics PACS
  • Oncology PACS
  • Pathology PACS
  • Ophthalmology PACS
  • Women’s health PACS
  • Others

By End User
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

By Country: Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Key Market Players


List of Companies Profiled in the Report:

  • Novarad Enterprise Healthcare Solutions
  • Escalon Medical Corp.
  • IBM Corporation
  • Siemens AG
  • Canon, Inc.
  • INFINITT Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Carestream Health, Inc.
  • Topcon Corporation

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Specialty PACS Market, by Deployment Model
1.4.2 LAMEA Specialty PACS Market, by Type
1.4.3 LAMEA Specialty PACS Market, by End User
1.4.4 LAMEA Specialty PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnership, Collaborations and Agreements: 2017, Jul – 2022, Jan) Leading Players
Chapter 4. LAMEA Specialty PACS Market by Deployment Model
4.1 LAMEA On premises Market by Country
4.2 LAMEA Cloud-based Market by Country
Chapter 5. LAMEA Specialty PACS Market by Type
5.1 LAMEA Radiology PACS Market by Country
5.2 LAMEA Orthopedics PACS Market by Country
5.3 LAMEA Oncology PACS Market by Country
5.4 LAMEA Pathology PACS Market by Country
5.5 LAMEA Ophthalmology PACS Market by Country
5.6 LAMEA Women’s health PACS Market by Country
5.7 LAMEA Other Type Market by Country
Chapter 6. LAMEA Specialty PACS Market by End User
6.1 LAMEA Hospitals & Clinics Market by Country
6.2 LAMEA Ambulatory Surgical Centers Market by Country
6.3 LAMEA Others Market by Country
Chapter 7. LAMEA Specialty PACS Market by Country
7.1 Brazil Specialty PACS Market
7.1.1 Brazil Specialty PACS Market by Deployment Model
7.1.2 Brazil Specialty PACS Market by Type
7.1.3 Brazil Specialty PACS Market by End User
7.2 Argentina Specialty PACS Market
7.2.1 Argentina Specialty PACS Market by Deployment Model
7.2.2 Argentina Specialty PACS Market by Type
7.2.3 Argentina Specialty PACS Market by End User
7.3 UAE Specialty PACS Market
7.3.1 UAE Specialty PACS Market by Deployment Model
7.3.2 UAE Specialty PACS Market by Type
7.3.3 UAE Specialty PACS Market by End User
7.4 Saudi Arabia Specialty PACS Market
7.4.1 Saudi Arabia Specialty PACS Market by Deployment Model
7.4.2 Saudi Arabia Specialty PACS Market by Type
7.4.3 Saudi Arabia Specialty PACS Market by End User
7.5 South Africa Specialty PACS Market
7.5.1 South Africa Specialty PACS Market by Deployment Model
7.5.2 South Africa Specialty PACS Market by Type
7.5.3 South Africa Specialty PACS Market by End User
7.6 Nigeria Specialty PACS Market
7.6.1 Nigeria Specialty PACS Market by Deployment Model
7.6.2 Nigeria Specialty PACS Market by Type
7.6.3 Nigeria Specialty PACS Market by End User
7.7 Rest of LAMEA Specialty PACS Market
7.7.1 Rest of LAMEA Specialty PACS Market by Deployment Model
7.7.2 Rest of LAMEA Specialty PACS Market by Type
7.7.3 Rest of LAMEA Specialty PACS Market by End User
Chapter 8. Company Profiles
8.1 Novarad Enterprise Healthcare Solutions
8.1.1 Company Overview
8.1.2 Recent Strategies and developments:
8.1.2.1 Partnerships, Collaborations and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.2 Escalon Medical Corp.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent Strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Siemens AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent Strategies and developments:
8.4.5.1 Partnerships, Collaborations and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisitions and Mergers:
8.4.6 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent Strategies and developments:
8.5.5.1 Partnerships, Collaborations and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 INFINITT Healthcare Co. Ltd.
8.6.1 Company Overview
8.6.2 Recent Strategies and developments:
8.6.2.1 Partnerships, Collaborations and Agreements:
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisitions and Mergers:
8.8 McKesson Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Carestream Health, Inc. (Onex Corporation)
8.9.1 Company Overview
8.10. Topcon Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Recent Strategies and developments:
8.10.4.1 Partnerships, Collaborations and Agreements:
8.10.4.2 Acquisitions and Mergers:

Companies Mentioned

  • Novarad Enterprise Healthcare Solutions
  • Escalon Medical Corp.
  • IBM Corporation
  • Siemens AG
  • Canon, Inc.
  • INFINITT Healthcare Co. Ltd.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Carestream Health, Inc.
  • Topcon Corporation

Methodology

Loading
LOADING...